Amgen, Inc. (AMGN)
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
Recs
baselineace
(64.48)
Submitted: 11/6/2009 11:34:03 PM :
Start Price:
$54.71
AMGN Score:
+1.15
Crazy low P/E. Severely undervalued
Recs
mtinvest
(30.76)
Submitted: 10/22/2009 6:06:41 PM :
Start Price:
$56.80
AMGN Score:
-2.18
Since 2003 the P/E ratio has been going down, while the ROE has been going up. Amgen is too cheap to be ignored at the current price level.
Recs
mrbill6
(< 20)
Submitted: 10/20/2009 9:29:50 PM :
Start Price:
$58.68
AMGN Score:
-4.87
navallier.investorplace.com rated: B, moneycentral.msn rated: 9 and smartmoney: undervalued
Recs
NewlyMinted4Star
(< 20)
Submitted: 10/12/2009 12:54:10 PM :
Start Price:
$59.92
AMGN Score:
-7.92
This account tracks the performance of newly minted 4 star stocks - 3 star stocks that recently turned in to 4 star stocks.
Recs
sharel23
(< 20)
Submitted: 9/28/2009 8:26:57 AM :
Start Price:
$60.33
AMGN Score:
-11.61
their stocks are down by 84% but rating are high
Recs
wofaintagain
(< 20)
Submitted: 9/20/2009 4:46:18 PM :
Start Price:
$62.22
AMGN Score:
+13.45
good company but overvalued for now
Recs
SequoiaStocks
(< 20)
Submitted: 9/18/2009 9:47:40 AM :
Start Price:
$60.72
AMGN Score:
-10.27
This account tracks the performance of the investment firm Ruane, Cunniff, and Goldfarb - the investment manager of Sequoia Fund.
Recs
sumbawa
(30.36)
Submitted: 9/17/2009 7:39:34 PM :
Start Price:
$60.80
AMGN Score:
-10.07
Low valuation, paying down debt, strong cash flow, promising pipeline. Stock will probably hold up well in any forthcoming correction.
Recs
aarconte
(< 20)
Submitted: 8/29/2009 5:36:36 AM :
Start Price:
$59.15
AMGN Score:
-12.86
because I knopw teh history of Amgen very positive
Recs
TMFBiologyFool
(92.02)
Submitted: 8/18/2009 5:34:54 PM :
Start Price:
$59.50
AMGN Score:
-17.90
A little too much punishment after the D-mab advisory committee.
Recs
ipfmanager
(98.28)
Submitted: 8/12/2009 6:34:35 PM :
Start Price:
$62.26
AMGN Score:
-18.85
Big day tomorrow. Working on Osteo fda guidence (not approval)
Recs
Kythyx
(< 20)
Submitted: 8/12/2009 1:49:36 PM :
Start Price:
$62.17
AMGN Score:
-18.97
Depends on FDA approval.
Recs
Survivn2
(64.65)
Submitted: 8/12/2009 3:51:33 AM :
Start Price:
$62.71
AMGN Score:
-21.39
I'm with motley fool top rated--outperform
Recs
auburnrulz
(61.37)
Submitted: 8/11/2009 3:35:54 PM :
Start Price:
$62.71
AMGN Score:
-21.39
new drug release
Recs
BLAYNE100
(87.28)
Submitted: 7/31/2009 11:19:50 PM :
Start Price:
$62.42
AMGN Score:
-20.60
Quality heathcare ready to rise
Recs
desidadda
(21.44)
Submitted: 7/31/2009 5:45:51 PM :
Start Price:
$62.42
AMGN Score:
-20.60
Amazing company. It will rocket up when their new drug gets out
Recs
schmidty32
(62.25)
Submitted: 7/28/2009 4:45:52 PM :
Start Price:
$62.62
AMGN Score:
-23.71
They are expected to have denosumab (a breakthrough drug for osteoporosis) approved.
Recs
nkpatten
(< 20)
Submitted: 7/8/2009 9:49:34 AM :
Start Price:
$60.55
AMGN Score:
-32.46
good defensive sector in current mkt (08/07/09)
Recs
kenqc
(74.90)
Submitted: 6/23/2009 11:13:02 AM :
Start Price:
$51.12
AMGN Score:
-13.64
a good pipeline, continued great r&d, a true long term winner with a great track record of bringing profitable drugs online. With the world wanting to live longer, the need and demand for their drugs will increase with this market leader.
Recs
goateyes
(86.19)
Submitted: 6/20/2009 10:21:32 PM :
Start Price:
$51.54
AMGN Score:
-12.06
I know some people from Amgen and I like what I hear..
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 340 1 2 3 4 5 6 7 8 9 10 Next »